198 related articles for article (PubMed ID: 25698462)
61. Is incidence of multiple HPV genotypes rising in genital infections?
Sohrabi A; Hajia M; Jamali F; Kharazi F
J Infect Public Health; 2017; 10(6):730-733. PubMed ID: 28215919
[TBL] [Abstract][Full Text] [Related]
62. Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples.
Dal Bello B; Spinillo A; Alberizzi P; Cesari S; Gardella B; Silini EM
J Clin Microbiol; 2009 Jul; 47(7):2175-80. PubMed ID: 19474270
[TBL] [Abstract][Full Text] [Related]
63. Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods.
Galan-Sanchez F; Rodriguez-Iglesias MA
APMIS; 2009 Oct; 117(10):708-15. PubMed ID: 19775338
[TBL] [Abstract][Full Text] [Related]
64. Oncogenic human papillomavirus genotyping by multiplex PCR and fragment analysis.
Souho T; Bennani B
J Virol Methods; 2014 Feb; 196():45-9. PubMed ID: 24183919
[TBL] [Abstract][Full Text] [Related]
65. [HPV detection and typing by INNO-LiPA assay on liquid cytology media Easyfix Labonord after extraction QIAamp DNA Blood Mini Kit Qiagen and Nuclisens easyMAG Biomérieux].
Hantz S; Goudard M; Marczuk V; Renaudie J; Dussartre C; Bakeland D; Denis F; Alain S
Pathol Biol (Paris); 2010 Apr; 58(2):179-83. PubMed ID: 19864084
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of the Roche MagNA Pure 96 nucleic acid extraction platform for the SPF10 line probe assay system.
Peng S; Yin J; Liu Y; Bi Z; Wu T; Qiao Y
J Appl Microbiol; 2023 Aug; 134(8):. PubMed ID: 37442630
[TBL] [Abstract][Full Text] [Related]
67. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
[TBL] [Abstract][Full Text] [Related]
68. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
Eder PS; Lou J; Huff J; Macioszek J
J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
[TBL] [Abstract][Full Text] [Related]
69. TEMPORARY REMOVAL: The original SPF
Geraets DT; Struijk L; Kleter B; Molijn A; van Doorn L; Quint WG; Colau B
J Virol Methods; 2014 Dec; 213C():1. PubMed ID: 25476446
[TBL] [Abstract][Full Text] [Related]
70. Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study.
Eklund C; Forslund O; Wallin KL; Dillner J
J Clin Microbiol; 2014 Feb; 52(2):449-59. PubMed ID: 24478473
[TBL] [Abstract][Full Text] [Related]
71. Analytical performance of newly developed multiplex human papillomavirus genotyping assay using Luminex xMAP™ technology (Mebgen™ HPV Kit).
Ozaki S; Kato K; Abe Y; Hara H; Kubota H; Kubushiro K; Kawahara E; Inoue M
J Virol Methods; 2014 Aug; 204():73-80. PubMed ID: 24768623
[TBL] [Abstract][Full Text] [Related]
72. High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method.
Cricca M; Marasco E; Alessandrini F; Fazio C; Prossomariti A; Savini C; Venturoli S; Chieco P; De Carolis S; Bonafè M; Re MC; Garagnani P; Mantovani V
New Microbiol; 2015 Apr; 38(2):211-23. PubMed ID: 25938746
[TBL] [Abstract][Full Text] [Related]
73. Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays.
Iftner T; Germ L; Swoyer R; Kjaer SK; Breugelmans JG; Munk C; Stubenrauch F; Antonello J; Bryan JT; Taddeo FJ
J Clin Microbiol; 2009 Jul; 47(7):2106-13. PubMed ID: 19420164
[TBL] [Abstract][Full Text] [Related]
74. Analytical performance of a low-cost multiplex polymerase chain reaction human papillomavirus genotyping assay for use in Sub-Saharan Africa.
Samwel K; Kahesa C; Mwaiselage J; Gonzalez D; West JT; Wood C; Palefsky J; Angeletti PC
J Med Virol; 2019 Feb; 91(2):308-316. PubMed ID: 30281790
[TBL] [Abstract][Full Text] [Related]
75. Human papillomavirus genotyping by 454 next generation sequencing technology.
Barzon L; Militello V; Lavezzo E; Franchin E; Peta E; Squarzon L; Trevisan M; Pagni S; Dal Bello F; Toppo S; Palù G
J Clin Virol; 2011 Oct; 52(2):93-7. PubMed ID: 21802982
[TBL] [Abstract][Full Text] [Related]
76. Using a new HPV detection system in epidemiological research: change of views on cervical dyskaryosis?
Reesink-Peters N; Burger MP; Kleter B; Quint WG; Bossuyt PM; Adriaanse AH
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):199-204. PubMed ID: 11574131
[TBL] [Abstract][Full Text] [Related]
77. Cross-sectional study of genital carcinogenic HPV infections in Paramaribo, Suriname: prevalence and determinants in an ethnically diverse population of women in a pre-vaccination era.
Geraets DT; Grünberg AW; van der Helm JJ; Schim van der Loeff MF; Quint KD; Sabajo LO; de Vries HJ
Sex Transm Infect; 2014 Dec; 90(8):627-33. PubMed ID: 24920666
[TBL] [Abstract][Full Text] [Related]
78. Human papillomavirus detected in esophageal squamous cell carcinoma in Iran.
Abdirad A; Eram N; Behzadi AH; Koriyama C; Parvaneh N; Akiba S; Kato T; Kahn N; Ghofrani M; Sadigh N
Eur J Intern Med; 2012 Mar; 23(2):e59-62. PubMed ID: 22284258
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
Jentschke M; Soergel P; Hillemanns P
J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
[TBL] [Abstract][Full Text] [Related]
80. Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in French women with poor adhesion to regular cervical screening.
Brun-Micaleff E; Coffy A; Rey V; Didelot MN; Combecal J; Doutre S; Daurès JP; Segondy M; Boulle N
J Med Virol; 2014 Mar; 86(3):536-45. PubMed ID: 24114972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
